CYTKHealthcareLarge-Cap

CYTOKINETICS INC Insider Trading Activity

Every SEC Form 4 insider transaction reported for CYTOKINETICS INC (CYTK), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are CYTK insiders buying or selling?

CYTOKINETICS INC insiders reported 2 open-market buys ($3.3M) and 399 sells ($170.2M) across 401 Form 4 filings — a net selling position of $166.9M.

Source: SEC EDGAR Form 4

Key Statistics (as of Jul 14, 2026)

Total Form 4 filings
401
SEC EDGAR
Insider filers
19
Insider buys (2)
$3.3M
Insider sells (399)
$170.2M

Insider sentiment

Net selling

Net insider flow of $166.9M in net selling.

Recent CYTK insider transactions

DateInsiderRoleTypeSharesPriceValue
Jul 14, 2026Robert I BlumPresident & CEOSale7.5K$82.02$615.1K
Jul 7, 2026Fady Ibraham MalikEVP Research & DevelopmentSale3.5K$86.62$303.2K
Jul 2, 2026Robert I BlumPresident & CEOSale7.5K$84.92$636.9K
Jul 2, 2026Andrew CallosEVP, Chief Commercial OfficerSale15.0K$85.80$1.3M
Jul 2, 2026Sung LeeEVP, Chief Financial OfficerSale1.1K$87.79$97.6K
Jun 29, 2026Sung LeeEVP, Chief Financial OfficerSale38.7K$82.30$3.2M
Jun 29, 2026Sung LeeEVP, Chief Financial OfficerSale3.1K$85.00$266.4K
Jun 23, 2026Fady Ibraham MalikEVP Research & DevelopmentSale3.5K$79.51$278.3K
Jun 15, 2026Robert I BlumPresident & CEOSale7.5K$70.46$528.5K
Jun 9, 2026Fady Ibraham MalikEVP Research & DevelopmentSale3.5K$67.98$237.9K
Jun 1, 2026Edward M. Kaye MDDirectorSale2.9K$76.09$223.2K
Jun 1, 2026Andrew CallosEVP, Chief Commercial OfficerSale15.0K$74.08$1.1M
Jun 1, 2026Lynne B ParshallDirectorSale5.0K$74.08$370.4K
May 28, 2026Robert I BlumPresident & CEOSale7.5K$77.21$579.1K
May 20, 2026Fady Ibraham MalikEVP Research & DevelopmentSale3.5K$75.69$264.9K
May 14, 2026Robert I BlumPresident & CEOSale7.5K$77.92$584.4K
May 5, 2026Fady Ibraham MalikEVP Research & DevelopmentSale3.5K$77.37$270.8K
May 5, 2026Wendell WierengaDirectorSale4.0K$75.00$302.4K
May 5, 2026Sung LeeEVP, Chief Financial OfficerSale23.9K$76.87$1.8M
May 5, 2026John T HendersonDirectorSale20.0K$75.97$1.5M
May 5, 2026Andrew CallosEVP, Chief Commercial OfficerSale11.3K$77.25$875.5K
May 4, 2026Andrew CallosEVP, Chief Commercial OfficerSale15.9K$65.00$1.0M
Apr 30, 2026Andrew CallosEVP, Chief Commercial OfficerSale15.0K$63.26$948.9K
Apr 29, 2026Robert I BlumPresident & CEOSale7.5K$59.62$447.1K
Apr 21, 2026Fady Ibraham MalikEVP Research & DevelopmentSale3.5K$65.69$229.9K

Showing the 25 most recent of 401 Form 4 filings for CYTOKINETICS INC.

Most active CYTK insiders

  • Robert I Blum141 filings
  • Fady Ibraham Malik113 filings
  • Andrew Callos27 filings
  • Sandford D Smith17 filings
  • Lynne B Parshall16 filings

Ask anything about CYTK insider activity

Use Trabud's AI agent to query CYTOKINETICS INC's Form 4 history in plain English — "Show me CYTK CEO purchases this year" or compare it against any other ticker.

Open the AI agent

CYTK insider trading FAQ

Are CYTOKINETICS INC insiders buying or selling?

Across 401 SEC Form 4 filings, CYTOKINETICS INC (CYTK) insiders reported 2 open-market purchases totaling $3.3M and 399 sales totaling $170.2M. That is a net selling position of $166.9M.

How many insiders trade CYTK stock?

19 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for CYTOKINETICS INC. The most recent filing was accepted on Jul 14, 2026.

Where does Trabud get CYTK insider trading data?

All CYTK insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content